# Oxytocin Add-on for Stable Depressed Patients

> **NCT01211756** · NA · TERMINATED · sponsor: **David Feifel** · enrollment: 1 (actual)

## Conditions studied

- Major Depressive Disorder
- Dysthymia Disorder

## Interventions

- **DRUG:** Oxytocin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01211756
- **Lead sponsor:** David Feifel
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-10
- **Primary completion:** 2015-02
- **Final completion:** 2015-12
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Break in funding
- **Last updated:** 2019-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01211756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01211756, "Oxytocin Add-on for Stable Depressed Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01211756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*